Literature DB >> 10684647

ATP-dependent dissociation of non-disulfide-linked aggregates of coagulation factor VIII is a rate-limiting step for secretion.

L Tagliavacca1, Q Wang, R J Kaufman.   

Abstract

Deficiency in coagulation factor VIII leads to the bleeding disorder hemophilia A. Previous studies demonstrated that factor VIII secretion is limited due to an ATP-requiring step early in the secretory pathway. In this report, we identified that this ATP-dependent rate-limiting step involves the dissociation of non-disulfide-linked aggregates within the endoplasmic reticulum (ER). In contrast to the numerous examples of interchain disulfide-linked aggregates, factor VIII is the first protein characterized to form non-disulfide-linked high molecular weight aggregates within the ER. Approximately a third of newly synthesized factor VIII was detected in high molecular weight aggregates. These aggregates disappeared over time as functional factor VIII appeared in the medium. The aggregated complexes did not require proteasomal degradation for clearance. Aggregate formation was enhanced by ATP depletion, and upon restoration of metabolic energy, these aggregates were dissociated and secreted. With the coexpression of von Willebrand factor (vWF), a small portion of vWF coaggregated with factor VIII. However, vWF dissociated from the aggregates more rapidly than factor VIII, supporting that these aggregates are dynamic. An increase in the factor VIII expression level elicited a corresponding increase in the fraction of factor VIII that was aggregated. In addition, a 110 amino acid sequence containing a hydrophobic beta-sheet within factor VIII was identified that may predispose factor VIII to aggregation. These data show that formation and ATP-dependent dissolution of nondisulfide-linked factor VIII aggregates is a dynamic, rate-limiting step during the folding process in the early secretory pathway. In summary, we have identified an unprecedented requirement for protein transport out of the ER that involves an ATP-dependent dissociation of non-disulfide-linked aggregates within the ER.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684647     DOI: 10.1021/bi991896r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Expression of human coagulation factor VIII in a human hybrid cell line, HKB11.

Authors:  Baisong Mei; Yaoqi Chen; Jianmin Chen; Clark Q Pan; John E Murphy
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

Review 2.  The evolving role of ubiquitin modification in endoplasmic reticulum-associated degradation.

Authors:  G Michael Preston; Jeffrey L Brodsky
Journal:  Biochem J       Date:  2017-02-15       Impact factor: 3.857

3.  Bioengineering of coagulation factor VIII for efficient expression through elimination of a dispensable disulfide loop.

Authors:  S R Selvaraj; A N Scheller; H Z Miao; R J Kaufman; Steven W Pipe
Journal:  J Thromb Haemost       Date:  2012-01       Impact factor: 5.824

4.  Antioxidants reduce endoplasmic reticulum stress and improve protein secretion.

Authors:  Jyoti D Malhotra; Hongzhi Miao; Kezhong Zhang; Anna Wolfson; Subramaniam Pennathur; Steven W Pipe; Randal J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

Review 5.  Gene therapy for hemophilia.

Authors:  Geoffrey L Rogers; Roland W Herzog
Journal:  Front Biosci (Landmark Ed)       Date:  2015-01-01

Review 6.  Diabetes-Associated Mutations in Proinsulin Provide a "Molecular Rheostat" of Nascent Foldability.

Authors:  Balamurugan Dhayalan; Michael A Weiss
Journal:  Curr Diab Rep       Date:  2022-02-04       Impact factor: 4.810

7.  Defects in Protein Folding and/or Quality Control Cause Protein Aggregation in the Endoplasmic Reticulum.

Authors:  Juthakorn Poothong; Insook Jang; Randal J Kaufman
Journal:  Prog Mol Subcell Biol       Date:  2021

8.  Factor VIII exhibits chaperone-dependent and glucose-regulated reversible amyloid formation in the endoplasmic reticulum.

Authors:  Juthakorn Poothong; Anita Pottekat; Marina Siirin; Alexandre Rosa Campos; Adrienne W Paton; James C Paton; Jacqueline Lagunas-Acosta; Zhouji Chen; Mark Swift; Niels Volkmann; Dorit Hanein; Jing Yong; Randal J Kaufman
Journal:  Blood       Date:  2020-05-21       Impact factor: 25.476

9.  Blood Clotting Factor VIII: From Evolution to Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov; A I Vorobiev
Journal:  Acta Naturae       Date:  2013-04       Impact factor: 1.845

10.  Transgene-host cell interactions mediate significant influences on the production, stability, and function of recombinant canine FVIII.

Authors:  Bredon Crawford; Margareth C Ozelo; Kenichi Ogiwara; James Ahlin; Silvia Albanez; Carol Hegadorn; Lori Harpell; Christine Hough; David Lillicrap
Journal:  Mol Ther Methods Clin Dev       Date:  2015-11-18       Impact factor: 6.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.